Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 9—September 2021
CME ACTIVITY - Research

Maternal Carriage in Late-Onset Group B Streptococcus Disease, Italy

Alberto BerardiComments to Author , Caterina Spada, Roberta Creti, Cinzia Auriti, Lucia Gambini, Vittoria Rizzo, Mariagrazia Capretti, Nicola Laforgia, Irene Papa, Anna Tarocco, Angela Lanzoni, Giacomo Biasucci, Giancarlo Piccinini, Giovanna Nardella, Giuseppe Latorre, Daniele Merazzi, Laura Travan, Maria Letizia Bacchi Reggiani, Lorenza Baroni, Matilde Ciccia, Laura Lucaccioni, Lorenzo Iughetti, and Licia Lugli
Author affiliations: Azienda Ospedaliero–Universitaria Policlinico, Modena, Italy (A. Berardi, C. Spada, L. Lucaccioni, L. Iughetti, L. Lugli); Istituto Superiore di Sanità, Rome, Italy (R. Creti); Ospedale Pediatrico Bambino Gesù, Rome (C. Auriti); Azienda Ospedaliero-Universitaria Policlinico, Parma, Italy (L. Gambini); Ospedale Civile M. Bufalini, Cesena, Italy (V. Rizzo); Azienda Ospedaliero–Universitaria S. Orsola–Malpighi, Bologna, Italy (M. Capretti, M.L. Bacchi Reggiani); Ospedale Policlinico, Bari, Italy (N. Laforgia); Ospedale Infermi, Rimini, Italy (I. Papa); Azienda Ospedaliero–Universitaria S. Anna, Ferrara, Italy (A. Tarocco); Ospedale Santa Maria della Scaletta, Imola, Italy (A. Lanzoni); Ospedale G. da Saliceto, Piacenza, Italy (G. Biasucci); Ospedale Santa Maria Delle Croci, Ravenna, Italy (G. Piccinini); Azienda Ospedaliero–Universitaria Ospedali Riuniti, Foggia, Italy (G. Nardella); Ospedale F. Miulli, Acquaviva delle Fonti, Italy (G. Latorre); Ospedale Valduce, Como, Italy (D. Merazzi); I; RCCS Materno Infantile Burlo Garofolo, Trieste, Italy (L. Travan); Arcispedale Santa Maria Nuova, Reggio Emilia, Italy (L. Baroni); Ospedale Maggiore, Bologna (M. Ciccia)

Main Article

Table 2

Maternal cultures of group B Streptococcus, Italy*

Culture Preterm cases, n = 18 Missed cases Full-term cases, n = 80 Missed cases p value Total cases, n = 98
Cultures before delivery
VR tested 18 (100) 0 80 (100) 0 NA 98 (100)
Positive culture 8 (44.4) 0 35 (43.8) 0 0.83 43 (43.9)
Urine tested 18 (100) 0 74 (92.5) 6 0.51 92 (93.9)
GBS bacteriuria†
0 (0)
0
2 (2.7)
0
0.85
2 (2.2)
Cultures at onset of LOD
VR tested 18 (100) 0 80 (100) 0 NA 98 (100)
Positive culture 7 (38.9) 0 51 (63.8) 0 0.09 58 (59.2)
Urine tested 18 (100) 0 72 (90.0) 8 0.36 90 (91.8)
GBS bacteriuria† 5 (27.8) 0 12 (16.7) 0 0.46 17 (18.9)
Breast milk tested‡ 15 (83.3) 3 68 (85.0) 12 0·85 83 (84.7)
Positive culture† 2 (13.3) 0 15 (22.1) 0 0.69 17 (20.5)

*Values are no. (%) except as indicated. Samples were obtained during pregnancy (urine), at prenatal screening (VR), and at onset of LOD (urine, VR, and breast milk). GBS, group B Streptococcus; LOD, late-onset disease; NA, not assessable; VR, vaginal/rectal. †Percentage and significance are calculated based on the patients who were tested. ‡Among 18 preterm neonates, 7 were exclusively fed breast milk (1 positive culture), 7 were fed pump-extracted milk (1 positive culture), 2 were fed formula milk, 1 was fed mixed breastmilk (missing culture), and 1 was fed donor human milk. Among 80 full-term neonates, 58 were exclusively fed breast milk (14 positive cultures and 1 missing culture), and 10 were fed mixed breast milk (1 positive culture and 1 missing culture).

Main Article

Page created: July 15, 2021
Page updated: August 19, 2021
Page reviewed: August 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external